Skip to content Skip to footer
Subscribe Now
Insights+ Key Biosimilars Events of May 2021
INSIGHTS+

Insights+ Key Biosimilars Events of May 2021

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potencyBiosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patientsDuring the month of May, Samsung initiated patient enrollment in the P-III…
June 3, 2021

Read more

Insights+ Key Biosimilars Events of April 2021
INSIGHTS+

Insights+ Key Biosimilars Events of April 2021

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potencyBiosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patientsDuring the month of April, Biocon and Viatris received EC's approval for…
May 6, 2021

Read more

Insights+ Key Biosimilars Events of November 2019
INSIGHTS+

Insights+ Key Biosimilars Events of November 2019

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to high-priced branded biologics, offering significant and much-needed cost savings to both payers and patients. Hence physicians are likely to adopt biosimilars 'a reference product to biologics' possessing similar…
December 6, 2019

Read more

Generics Pharma Companies Top 20 2018
TOP 20

Top 20 Generics Pharma Companies Based On 2018 Revenue

The global generics pharmaceutical market is continuously growing and increasing with its accessibility & benefits offered as efficient and economical drugs- are always needed in the market. Generics are approved copies of small molecule drugs which contain the same amount of active ingredients- dosage form- safety- strength- route of administration- quality- performance characteristics- as of…
September 13, 2019

Read more

Insights+ Key Biosimilars Events of July 2019
INSIGHTS+

Insights+ Key Biosimilars Events of July 2019

Biosimilars are key alternatives for costly Biologics therapies and saving million dollars of patients in multiple diseases. Hence physicians are likely to adopt biosimilars 'a reference product to biologics' which are biologically like biologics. They possess similar therapeutic properties in terms of potency, safety, and efficacy to original biologic products. Our team at PharmaShots have…
August 10, 2019

Read more